Sofia, Jobelyn M.

HRN: 05-04-39  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/02/2026
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
04/03/2026
04/10/2026
IV
500mg
Q8h
Cholelithiasis With No Signs Of Cholecystitis
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Intra-abdominal    Compliance to guidelines: